# A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases

> **NCT07731685** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 26 (estimated)

## Conditions studied

- Pain in Bone Metastases

## Interventions

- **DRUG:** VC004 low dose
- **DRUG:** VC004 high dose
- **DRUG:** VC004 placebo

## Key facts

- **NCT ID:** NCT07731685
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07731685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07731685, "A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07731685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*